Tracking ABEO? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Abeona Therapeutics Inc. (ABEO) short interest & options flow

NASDAQ

Abeona Therapeutics delivered a clean Q1 earnings beat this morning, but the short side is not moving. Revenue of $8.72M crushed the $4.57M consensus by a wide margin. EPS came in at -$0.30, five cents better than the -$0.35 estimate. Management reported continued expansion of its pz-cel treatment center network — the key commercial driver for its FDA-approved cell therapy for…

$4.41-0.45% 1d-10.00% 1w-20.83% 1mClose: 19 Oct 2026

Short interest % of float: High
Cost to borrow: Low
Availability: Low
Put / call ratio

Market cap: $252M
Next earnings: 13 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 20 Oct 2026

ABEO news and analysis

RSS

No long-form analysis yet for ABEO. Pulse alerts and the live data picture are available on ORTEX.

Open ABEO on ORTEX →

Want the live picture for ABEO?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABEO — free to start on ORTEX.